Literature DB >> 17169238

High-dose atorvastatin versus usual-dose simvastatin for secondary prevention after myocardial infarction.

Michael Clearfield.   

Abstract

Entities:  

Year:  2007        PMID： 17169238

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN： 1523-3804            Impact factor:   5.113


× No keyword cloud information.
  16 in total

Review 1.  Optimal low-density lipoprotein is 50 to 70 mg/dl: lower is better and physiologically normal.

Authors:  James H O'Keefe; Loren Cordain; William H Harris; Richard M Moe; Robert Vogel
Journal:  J Am Coll Cardiol       Date:  2004-06-02       Impact factor: 24.094

2.  Biomedicine. Lowering LDL--not only how low, but how long?

Authors:  Michael S Brown; Joseph L Goldstein
Journal:  Science       Date:  2006-03-24       Impact factor: 47.728

3.  Effects of the acyl coenzyme A:cholesterol acyltransferase inhibitor avasimibe on human atherosclerotic lesions.

Authors:  Jean-Claude Tardif; Jean Grégoire; Philippe L L'Allier; Todd J Anderson; Olivier Bertrand; Francois Reeves; Lawrence M Title; Fernando Alfonso; Erick Schampaert; Alita Hassan; Richard McLain; Milton L Pressler; Reda Ibrahim; Jacques Lespérance; John Blue; Therese Heinonen; Josep Rodés-Cabau
Journal:  Circulation       Date:  2004-11-08       Impact factor: 29.690

4.  Effect of pravastatin on coronary disease events in subgroups defined by coronary risk factors: the Prospective Pravastatin Pooling Project.

Authors:  F M Sacks; A M Tonkin; J Shepherd; E Braunwald; S Cobbe; C M Hawkins; A Keech; C Packard; J Simes; R Byington; C D Furberg
Journal:  Circulation       Date:  2000-10-17       Impact factor: 29.690

5.  Statin safety: lessons from new drug applications for marketed statins.

Authors:  Terry A Jacobson
Journal:  Am J Cardiol       Date:  2006-02-02       Impact factor: 2.778

6.  Intensive lipid lowering with atorvastatin in patients with stable coronary disease.

Authors:  John C LaRosa; Scott M Grundy; David D Waters; Charles Shear; Philip Barter; Jean-Charles Fruchart; Antonio M Gotto; Heiner Greten; John J P Kastelein; James Shepherd; Nanette K Wenger
Journal:  N Engl J Med       Date:  2005-03-08       Impact factor: 91.245

7.  Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial.

Authors:  Steven E Nissen; E Murat Tuzcu; Paul Schoenhagen; B Greg Brown; Peter Ganz; Robert A Vogel; Tim Crowe; Gail Howard; Christopher J Cooper; Bruce Brodie; Cindy L Grines; Anthony N DeMaria
Journal:  JAMA       Date:  2004-03-03       Impact factor: 56.272

8.  Usefulness of lowering low-density lipoprotein cholesterol to <70 mg/dl and usefulness of C-reactive protein in patient selection.

Authors:  Steven M Kent; Allen J Taylor
Journal:  Am J Cardiol       Date:  2003-11-15       Impact factor: 2.778

9.  High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.

Authors:  D J Gordon; J L Probstfield; R J Garrison; J D Neaton; W P Castelli; J D Knoke; D R Jacobs; S Bangdiwala; H A Tyroler
Journal:  Circulation       Date:  1989-01       Impact factor: 29.690

10.  MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.

Authors: 
Journal:  Lancet       Date:  2002-07-06       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.